Hannover ESSO Fellowship specifically peritoneal surface malignancy కోసం. Prof. Beate Rau దగ్గర train అయ్యాను. CRS, HIPEC, PIPAC అన్నీ offer చేస్తున్నాను. My Hannover ESSO Fellowship was specifically for peritoneal surface malignancy. I trained under Prof. Beate Rau. I offer CRS, HIPEC and PIPAC.
Peritoneum abdominal cavity ని line చేసే membrane. ఈ membrane కి cancer spread అవడాన్ని peritoneal metastasis అంటాము. Most common sources: colorectal cancer, ovarian cancer, gastric cancer, appendix cancer.
Historically peritoneal metastasis "terminal" గా consider చేసేవారు. ఇప్పుడు, Sugarbaker (USA) మరియు Glehen (Lyon, France) వంటి pioneers యొక్క work ద్వారా, selected cases లో CRS+HIPEC long-term disease control, కొన్నిసార్లు cure possible అని established అయింది.
నా Hannover Fellowship లో Prof. Beate Rau దగ్గర specifically ఈ cases evaluate చేయడం, PCI score calculate చేయడం, surgery plan చేయడం నేర్చుకున్నాను. "Inoperable peritoneal cancer" అని referred అయిన patients లో significant number surgery candidates అవుతున్నారు నా practice లో.
The peritoneum is the membrane lining the abdominal cavity. Cancer spreading to this membrane is called peritoneal metastasis. The most common sources are colorectal cancer, ovarian cancer, gastric cancer and appendix cancer.
Peritoneal metastasis was historically considered terminal. Now, through the work of pioneers like Sugarbaker (USA) and Glehen (Lyon, France), it is established that CRS+HIPEC can achieve long-term disease control and sometimes cure in selected cases.
During my Hannover Fellowship under Prof. Beate Rau, I learned specifically how to evaluate these cases, calculate PCI scores and plan surgery. In my practice, a significant number of patients referred as having "inoperable peritoneal cancer" do become surgical candidates.
Cytoreductive Surgery removes all visible tumour deposits. Heated chemotherapy (42°C) circulates inside the abdomen for 60-90 minutes. PCI below 20 gives best outcomes. My primary area of fellowship training.
Pressurised Intraperitoneal Aerosol Chemotherapy. Laparoscopic, repeatable every 6 weeks. For patients not suitable for open CRS+HIPEC. Provides systemic treatment access to peritoneal surfaces.
Surgery alone is not enough. Systemic chemotherapy, targeted therapy and the CION Tumor Board plan coordinates all treatment. I refer for the best non-surgical option when surgery is not appropriate.